MedPath

Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients

Not Applicable
Completed
Conditions
Diabetes
Hypertension
Dyslipidemia
Coronary Arteriosclerosis
Interventions
Behavioral: Behavioral counseling and peer support
Behavioral: Interactive Education
Behavioral: Role modeling
Procedure: Pharmacologic case management
Registration Number
NCT00357955
Lead Sponsor
Providence VA Medical Center
Brief Summary

The purpose of this research is to study whether a multidisciplinary education in Diabetes and intervention for cardiac risk reduction in a group setting to modify patient behavior and adjust medications can achieve diabetes guideline goals for glycemia, blood pressure and lipid control.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
118
Inclusion Criteria
  • All diabetic veterans with a Hb-A1c between 7.0- 9.0 % within the last 6 months will be eligible for the study
Exclusion Criteria
  • Patients without an Hb-A1c checked within the last 6 months.
  • Patients who are unable to attend the group sessions, either because of lack of transportation, psychiatric instability (suicidal, psychotic), or organic brain injury that preclude them from diabetes self-care.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MEDICBehavioral counseling and peer supportMultidisciplinary education and diabetes intervention for cardiac risk reduction
MEDICInteractive EducationMultidisciplinary education and diabetes intervention for cardiac risk reduction
MEDICRole modelingMultidisciplinary education and diabetes intervention for cardiac risk reduction
MEDICPharmacologic case managementMultidisciplinary education and diabetes intervention for cardiac risk reduction
Primary Outcome Measures
NameTimeMethod
Percentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm Hg4 months

The major outcome was the percentage of participants who attain the target goals for A1C, blood pressure,and ldl cholesterol lipids set by the American Diabetes Association guidelines, defined as A1C \<7%, SBP \<130 mm Hg, diastolic blood pressure (DBP) \<80 mm Hg, and LDL cholesterol \<100 mg/dL (2.6 mmol/L).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Providence VAMC

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath